Cidara Therapeutics, Inc. (CDTX)

219.60 -0.69 (-0.31%) USD  |  NASDAQ  |  Dec 10, 16:00
219.50 -0.10 (-0.05%) Pre-Market: 08:34
More

Cidara Therapeutics Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for CDTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Merck & Co., Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Johnson & Johnson Upgrade
Mersana Therapeutics, Inc. Upgrade
Pfizer Inc. Upgrade